2-[(18)F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer

This study aimed to compare CE-CT and 2-[(18)F]FDG-PET/CT for response monitoring metastatic breast cancer (MBC). The primary objective was to predict progression-free and disease-specific survival for responders vs. non-responders on CE-CT and 2-[(18)F]FDG-PET/CT. The secondary objective was to ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogsen, Marianne, Naghavi-Behzad, Mohammad, Harbo, Frederik Graae, Jakobsen, Nick Møldrup, Gerke, Oke, Asmussen, Jon Thor, Nissen, Henriette Juel, Dahlsgaard-Wallenius, Sara Elisabeth, Braad, Poul-Erik, Jensen, Jeanette Dupont, Ewertz, Marianne, Hildebrandt, Malene Grubbe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076261/
https://www.ncbi.nlm.nih.gov/pubmed/37019987
http://dx.doi.org/10.1038/s41598-023-32727-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076261/
https://www.ncbi.nlm.nih.gov/pubmed/37019987
http://dx.doi.org/10.1038/s41598-023-32727-w

Ejemplares similares